Research
Hormonal
Discontinuation of insulin is achieved at a mean weight reduction of 11% of initial body weight, while sulfonylureas require 14% and sitagliptin 7.1%.
Different diabetes medications come off at different weight loss milestones. Sitagliptin may be discontinued after ~7% weight loss, insulin after ~11%, and sulfonylureas after ~14%. Your doctor will monitor your blood sugar to determine the right time to adjust each specific medication.
ModerateQualifiesMEDIUM confidence
The mean percentage weight loss that was associated with discontinuing sulfonylureas, insulin and sitagliptin were 14.0% (19.1 ± 8.2 kgs), 11.4% (15.6 ± 5.5 kgs), and 7.1% (9.7 ± 2.1 kgs), respectively.
Why this rating
Retrospective cohort, small sample sizes for specific drug classes.
Source
Intentional Weight Loss and Dose Reductions of Anti-Diabetic Medications – A Retrospective Cohort Study
Anita Kumar et al. · PLoS ONE · 2012
DOI 10.1371/journal.pone.0032395
cohort · n=50Cited 26×
Read the paper DOI resolved against Crossref · corpus check 2026-06-10
More from this paper
- Intentional weight loss of 7–14% of initial body weight typically enables the discontinuation of anti-diabetic medications in overweight or obese patients with type 2 diabetes.Moderate
- For every 5% weight loss, the predicted dose reduction for sulfonylureas, insulin, and any anti-diabetic medication is 39%, 42%, and 49%, respectively.Moderate
Related findings · Hormonal
- Initial treatment for type 2 diabetes should be a combination of metformin and either an SGLT-2 inhibitor or a GLP-1 receptor agonist to achieve cardiorenal protection, rather than monotherapy or older agents like sulfonylureas.Strong
- For patients with specific monogenic obesity syndromes (leptin deficiency, POMC/PCSK1/LEPR mutations), targeted pharmacotherapy (recombinant leptin or setmelanotide) is highly effective and should be prioritized, unlike in polygenic obesity.Strong
- Continued weekly administration of 2.4 mg subcutaneous semaglutide prevents weight regain and promotes further weight loss in adults with overweight or obesity, whereas switching to placebo results in significant weight regain.Strong
This is one finding among thousands. Every one is graded and traced to its source, so you can see what the evidence actually supports. Browse the research →